thymoquinone has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, M; Al-Dayel, F; Al-Kuraya, KS; Bavi, PP; Hussain, AR; Uddin, S | 1 |
1 other study(ies) available for thymoquinone and Diffuse Large B-Cell Lymphoma
Article | Year |
---|---|
Phosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Cell Line, Tumor; Cohort Studies; Female; Humans; I-kappa B Proteins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; NF-KappaB Inhibitor alpha; Nigella sativa; Phosphorylation; Prognosis; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2013 |